Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Shares of Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five analysts that are covering the firm, MarketBeat.com reports.

Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. 99.1% of AtriCure shares are owned by institutional investors. Comparatively ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

PORTLAND, IL, UNITED STATES, January 30, 2025 /EINPresswire / -- Increase in the number of spinal & joint <a target=_blank href= ...

Check the time stamp on this data. Updated AI-Generated Signals for Orthofix Medical Inc. (OFIX) available here: OFIX. Type a few symbols and Take a Trial. The signals for these will appear ...

Corporate crises happen—and that means we have to plan for them. While it isn’t practical to prepare for every possible corporate crisis, there ...

GET MORE AI-GENERATED SIGNALS: January 16, 2025, 22:48 pm ET, BY Bill T.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...